1. Home
  2. AXDX vs FGL Comparison

AXDX vs FGL Comparison

Compare AXDX & FGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXDX
  • FGL
  • Stock Information
  • Founded
  • AXDX 1982
  • FGL 2021
  • Country
  • AXDX United States
  • FGL Malaysia
  • Employees
  • AXDX N/A
  • FGL N/A
  • Industry
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • FGL
  • Sector
  • AXDX Industrials
  • FGL
  • Exchange
  • AXDX Nasdaq
  • FGL NYSE
  • Market Cap
  • AXDX 13.7M
  • FGL 21.0M
  • IPO Year
  • AXDX 1996
  • FGL 2024
  • Fundamental
  • Price
  • AXDX $0.14
  • FGL $1.27
  • Analyst Decision
  • AXDX
  • FGL
  • Analyst Count
  • AXDX 0
  • FGL 0
  • Target Price
  • AXDX N/A
  • FGL N/A
  • AVG Volume (30 Days)
  • AXDX 425.6K
  • FGL 62.3K
  • Earning Date
  • AXDX 05-16-2025
  • FGL 06-21-2025
  • Dividend Yield
  • AXDX N/A
  • FGL N/A
  • EPS Growth
  • AXDX N/A
  • FGL N/A
  • EPS
  • AXDX N/A
  • FGL N/A
  • Revenue
  • AXDX $11,698,000.00
  • FGL $20,205,441.00
  • Revenue This Year
  • AXDX $7.25
  • FGL N/A
  • Revenue Next Year
  • AXDX N/A
  • FGL N/A
  • P/E Ratio
  • AXDX N/A
  • FGL N/A
  • Revenue Growth
  • AXDX N/A
  • FGL N/A
  • 52 Week Low
  • AXDX $0.12
  • FGL $1.16
  • 52 Week High
  • AXDX $2.09
  • FGL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • AXDX 14.62
  • FGL N/A
  • Support Level
  • AXDX $0.50
  • FGL N/A
  • Resistance Level
  • AXDX $0.56
  • FGL N/A
  • Average True Range (ATR)
  • AXDX 0.05
  • FGL 0.00
  • MACD
  • AXDX -0.01
  • FGL 0.00
  • Stochastic Oscillator
  • AXDX 4.44
  • FGL 0.00

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

About FGL FOUNDER GROUP LTD

Founder Group Ltd acts as an end-to-end Engineering, Procurement, Construction, and Commissioning solutions provider for solar PV facilities in Malaysia. The segments of the company are large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects of the company are utility-scale solar PV power plants with installed generating capacity of 1 MWac or more, and C&I projects of the company are smaller-scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their consumption at factories, warehouses, and commercial stores. The company derives its revenue from Malaysia.

Share on Social Networks: